Science & Enterprise subscription

Please share Science & Enterprise

RSS
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn

Cannabis Drug Approved by FDA for Rare, Severe Seizures

Cannabis plant

A drug based on chemicals derived from cannabis plants was approved by Food and Drug Administration for marketing in the U.S. to treat seizures associated with two rare and severe forms of epilepsy. . . . → Read More: Cannabis Drug Approved by FDA for Rare, Severe Seizures

Cancer T-Cell Start-Up Gains $150 Million in IPO

NASDAQ share price display

A three year-old company developing treatments for cancer with engineered T-cells from the immune system raised $150 million in its initial public offering of common stock. . . . → Read More: Cancer T-Cell Start-Up Gains $150 Million in IPO

Electrodes for Implants 3-D Printed on Soft Materials

Electrodes on gummy bears

An engineering team produced with an ink-jet printer working electrodes like those used in medical implants on bio-friendly soft materials rather than metal or silicon. . . . → Read More: Electrodes for Implants 3-D Printed on Soft Materials

Gates Backs Engineered Mosquitoes to Stop Malaria

Anopheles mosquito

A company that applies genetic engineering to limit the spread of disease-carrying pests is partnering with the Bill and Melinda Gates Foundation to develop mosquitoes that stop the spread of malaria. . . . → Read More: Gates Backs Engineered Mosquitoes to Stop Malaria

UC-Berkeley Gains U.S. Crispr-Cas9 Patent

Editing DNA

University of California received a patent for its genome editing technology known as Crispr, with the most widely used editing enzyme called Cas9. . . . → Read More: UC-Berkeley Gains U.S. Crispr-Cas9 Patent

115M Euro Grant for Precision Medicine, Trials in Autism

Autism graphic

A new initiative in Europe is investigating the connection between a person’s molecular composition and autism, particularly when other disorders complicate that individual’s condition. . . . → Read More: 115M Euro Grant for Precision Medicine, Trials in Autism

$850M Deal Kicks Off RNA Vaccine Research

RNA strand illustration

Drug maker Sanofi is partnering with biotechnology company Translate Bio to develop vaccines against infectious diseases from messenger RNA, material transcribed from genetic codes in DNA. . . . → Read More: $850M Deal Kicks Off RNA Vaccine Research

Data Tools Designed for Genomics-Based Precision Cancer Care

Computational biology illustration

A computerized system is available that analyzes the genomic composition of cancer patients and recommends personalized treatments that its designers say take into account a larger array of factors than comparable systems. . . . → Read More: Data Tools Designed for Genomics-Based Precision Cancer Care

FDA Delays Crispr Trial for Inherited Blood Diseases

Crispr-Cas9 illustration

The U.S. Food and Drug Administration put a hold on beginning a clinical trial of the emerging genome editing technique known as Crispr to treat inherited blood disorders. . . . → Read More: FDA Delays Crispr Trial for Inherited Blood Diseases

New ALS Drug Formula Shown Active, Safe

Neurons

A new formulation of a current drug to treat amyotrophic lateral sclerosis, or ALS, shows in its first clinical trial the drug produces more active ingredients against ALS than the current drug and causes no safety concerns. . . . → Read More: New ALS Drug Formula Shown Active, Safe